These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 2894728

  • 1. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
    Mayumi H, Good RA.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):139-41. PubMed ID: 2894728
    [No Abstract] [Full Text] [Related]

  • 2. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
    Mayumi H, Good RA.
    Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
    [Abstract] [Full Text] [Related]

  • 3. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T, Tomita Y, Zhang QW, Shimizu I, Nomoto K, Yasui H.
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [Abstract] [Full Text] [Related]

  • 4. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients.
    Mayumi H, Himeno K, Tanaka K, Tokuda N, Fan JL, Nomoto K.
    Transplantation; 1986 Oct; 42(4):417-22. PubMed ID: 3532453
    [Abstract] [Full Text] [Related]

  • 5. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
    Mayumi H, Himeno K, Tokuda N, Fan JL, Nomoto K.
    Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
    [Abstract] [Full Text] [Related]

  • 6. Drug-induced tolerance to allografts in mice. VIII. Effects of thymectomy and/or splenectomy on tolerance induction in an H-2-haplotype-identical strain combination.
    Mayumi H, Himeno K, Tokuda N, Nomoto K.
    Transplantation; 1985 Oct; 40(4):438-41. PubMed ID: 4049497
    [No Abstract] [Full Text] [Related]

  • 7. Drug-induced tolerance to allografts in mice. VII. Optimal protocol and mechanism of cyclophosphamide-induced tolerance in an H-2 haplotype-identical strain combination.
    Mayumi H, Himeno K, Tokuda N, Nomoto K.
    Transplant Proc; 1986 Apr; 18(2):363-9. PubMed ID: 3515673
    [No Abstract] [Full Text] [Related]

  • 8. Murine skin allograft histocompatibility combinations susceptible to induction of tolerance by intraportal inoculation of allogeneic spleen cells.
    Yabusaki N, Komatsu H, Tasaka K, Ueno A.
    Transplant Proc; 1993 Apr; 25(2):2124-5. PubMed ID: 8470290
    [No Abstract] [Full Text] [Related]

  • 9. Drug-induced tolerance to allografts in mice. III. Prolongation of skin graft survival by tolerance induction in congenic mice disparate in the major H-2 antigens.
    Shin T, Himeno K, Mayumi H, Nomoto K.
    Transplantation; 1985 Mar; 39(3):333-5. PubMed ID: 3883602
    [No Abstract] [Full Text] [Related]

  • 10. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN, Lee J, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Kwon CH, Joh JW, Kim SJ.
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [Abstract] [Full Text] [Related]

  • 11. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.
    J Immunol; 1995 Nov 01; 155(9):4179-88. PubMed ID: 7594573
    [Abstract] [Full Text] [Related]

  • 12. [Induction of tolerance to alloantigens in adult mice].
    Cherniakhovskaia IIu, Nagurskaia EV, Shaposhnikova GB, Fontalin LN.
    Biull Eksp Biol Med; 1980 Mar 01; 89(3):320-2. PubMed ID: 6992878
    [Abstract] [Full Text] [Related]

  • 13. Cyclophosphamide-induced tolerance in fully allogeneic heart transplantation in mice.
    Matsuura A, Katsuno M, Suzuki Y, Ito T, Yasuura K, Abe T, Yoshikai Y.
    Cell Immunol; 1994 May 01; 155(2):501-7. PubMed ID: 8181080
    [Abstract] [Full Text] [Related]

  • 14. Thymus dependency of bone marrow stem cell proliferation in response to certain antigens.
    Frindel E, Leuchars E, Davies AJ.
    Exp Hematol; 1976 Sep 01; 4(5):275-84. PubMed ID: 789103
    [Abstract] [Full Text] [Related]

  • 15. Prolonged skin allograft survival in Scid mice reconstituted with isogeneic bone marrow stem cell antigen-1-positive cells and thymus tissue.
    Gao Z, Tibbles L, Yilmaz S, Gao Y, MacDonald A.
    Transplant Proc; 2005 Jun 01; 37(5):2300-2. PubMed ID: 15964404
    [Abstract] [Full Text] [Related]

  • 16. Specific immune suppression in adult mice across K-I-D fully allogeneic histoincompatibility barriers induced by lymphocyte-free bone marrow cells.
    Müller-Ruchholtz W, Blank M, Wottge HU, Müller-Hermelink HK.
    Transplant Proc; 1981 Mar 01; 13(1 Pt 1):603-7. PubMed ID: 7022898
    [No Abstract] [Full Text] [Related]

  • 17. Drug-induced tolerance to allografts in mice. VI. Tolerance induction in H-2-haplotype-identical strain combinations in mice.
    Mayumi H, Himeno K, Shin T, Nomoto K.
    Transplantation; 1985 Aug 01; 40(2):188-94. PubMed ID: 3895627
    [Abstract] [Full Text] [Related]

  • 18. Cyclophosphamide-induced chimerism.
    Glynn JP, Fefer A, Halpern BL.
    Cancer Res; 1968 Jan 01; 28(1):41-3. PubMed ID: 4169583
    [No Abstract] [Full Text] [Related]

  • 19. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
    Tomita Y, Shimizu I, Iwai T, Zhang QW, Okano S, Kajiwara T, Onzuka T, Tominaga R.
    Scand J Immunol; 2006 Oct 01; 64(4):392-7. PubMed ID: 16970680
    [Abstract] [Full Text] [Related]

  • 20. Modulation of allotransplantation tolerance induction by interleukin-1 and interleukin-2.
    Holán V.
    J Immunogenet; 1988 Oct 01; 15(5-6):331-7. PubMed ID: 3076594
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.